Global Pyrogen Testing Market Report and Forecast 2024-2032

Global Pyrogen Testing Market Outlook

The global market size for pyrogen testing reached a value of more than USD 1.35 billion in 2023. The global pyrogen testing market is expected to grow at a CAGR of 11.7% between 2024 and 2032, reaching a value of USD 3.65 billion by 2032.

Key Trends in the Market

Pyrogens are substances known to cause fever and pyrogen testing is a method that is used to test the presence or absence of pyrogens in medical devices and parenteral pharmaceutical products. It is an important step to avoid the life-threatening reactions of fever caused by the pyrogenic substances. Pyrogen testing is carried out in cool atmospheres or in air-conditioned spaces. 

• Chronic diseases are on the rise, as well as infectious diseases that are spreading rapidly among people, increasing the need for medical devices and parenteral medication. This has largely contributed to the growth of the market for pyrogen testing.

• Developments such as the monocyte activation test among other tests and technological advancements in pyrogen testing have greatly contributed to the growth of the market. Such tests are helping replace tests such as rabbit pyrogen testing, which face criticism due to their use of animals.

• With increased competition amongst pharmaceutical and biotechnology companies, particularly for the manufacturing of new devices and drugs for treatment, pyrogen testing is a crucial step to develop new treatment. The pyrogen testing market is expected to grow in the coming years, fuelled by growing demand from manufacturers and developers of new devices and pharmaceuticals.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

Based on product type, the pyrogen testing market can be divided into kits and reagents, services, and instruments. By test type, the market is categorised into LAL test, rabbit pyrogen tests, and monocyte activation test, among others. The LAL Test segment is subdivided into chromogenic tests, turbidimetric tests, and gel clot tests. On the basis of end use, the market is segmented into medical devices, pharmaceutical companies, and biotechnology companies, among others. Based on region, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global pyrogen testing market covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.

• Charles River Laboratories International Inc.

• Merck KGaA

• Microcoat Biotechnologie GmbH

• Ellab A/S

• Lonza Group

• Others

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Share by Test Type

The LAL test type is expected to hold the largest share in the pyrogen testing market owing to its sensitivity that is 3 to 300 times more than the rabbit pyrogen tests and its ability to procure results using less amount of sample. Results are given in not more than an hour and is cost saving, encouraging its increased demand thereby contributing to the growth of the LAL test segment in the market. 

Rabbit pyrogen test lacks robustness owing to the difference in reaction between a human and an animal. Growing concerns regarding animal abuse are also resulting in lowered popularity of rabbit pyrogen tests. 

Market Share by Region

North America has held a leading share in the market for pyrogen testing because of the prevalence of chronic as well as infectious diseases that require pyrogen testing. Other factors such as increase in the number of pharmaceutical companies and presence of key players have also helped the growth of the market in the North America region. 

Countries in North America such as the United States have developed healthcare infrastructure and streamlined regulatory systems governing healthcare, supporting the pyrogen testing market. With a growing geriatric population and increase in healthcare complications, the need for medical devices and parenteral pharmaceuticals will expand in coming years. 

Meanwhile, developments in healthcare systems in the Asia Pacific are likely to lead to a heightened demand for pyrogen testing in the region. 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

Charles River Laboratories International Inc. is an international pharmaceutical company that has its headquarter in Massachusetts, United States. It was founded in 1947 and provides cell therapy, clinical and preclinical laboratory, and gene therapy services to pharmaceutical, biotechnology, and medical device companies.

Merck KGaA founded in 1668 is headquartered in Darmstadt in Germany. It is a multinational pharmaceutical and science and technology company that aims at improving the quality of life worldwide of every individual by carrying out innovations based on life sciences.

Microcoat Biotechnologie GmbH was founded in 1992 and is based out of Bavaria in Germany. It is a biotechnology company that provides services such as kit manufacturing, solid phase coating, and diagnostic testing. 

Other market players include Ellab A/S, and Lonza Group, among others.

Key Highlights of the Report